• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.

作者信息

Eddleston J M, Pollard B J, Blades J F, Doran B

机构信息

Department of Anaesthesia, Manchester Royal Infirmary, UK.

出版信息

Intensive Care Med. 1995 Apr;21(4):342-7. doi: 10.1007/BF01705413.

DOI:10.1007/BF01705413
PMID:7650257
Abstract

OBJECTIVE

To assess the requirement for propofol to provide sedation in critically ill patients in established renal failure during the commencement of haemodiafiltration.

DESIGN

Prospective clinical study.

SETTING

ICU, University Hospital.

PATIENTS

10 adult patients. All were mechanically ventilated, had acute oliguric renal failure which necessitated continuous veno-venous haemodiafiltration and were receiving a continuous intravenous infusion of propofol for sedation. Sedation was assessed using a scoring system.

INTERVENTION

Veno-venous haemodiafiltration.

MEASUREMENTS AND RESULTS

Connection of the extracorporeal circuit produced a reduction in plasma propofol concentration in 7 out of 9 patients (one sample misplaced) with subsequent awakening in 3 of these 7 patients. The commencement of haemodiafiltration itself did not significantly influence the requirement for propofol (8 out of 10 patients).

CONCLUSION

Haemodiafiltration does not substantially influence the requirement for propofol but the initial introduction of the extracorporeal circuit will reduce plasma concentrations in the majority of patients. This may be due to haemodilution alone or absorption of plasma albumin (with propofol) onto the membrane.

摘要

相似文献

1
The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.
Intensive Care Med. 1995 Apr;21(4):342-7. doi: 10.1007/BF01705413.
2
A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient.一种基于药代动力学的丙泊酚给药策略,用于危重症机械通气儿科患者的镇静。
Crit Care Med. 1996 Sep;24(9):1473-81. doi: 10.1097/00003246-199609000-00008.
3
Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.临床镇静评分作为重症监护病房患者镇静和镇痛药物暴露的指标。
Am J Geriatr Pharmacother. 2007 Sep;5(3):218-31. doi: 10.1016/j.amjopharm.2007.10.005.
4
Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients.脓毒症患者持续静-静脉血液透析滤过过程中降钙素原的清除及血浆浓度变化
Eur J Anaesthesiol. 2000 Nov;17(11):665-71. doi: 10.1046/j.1365-2346.2000.00758.x.
5
Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients.在重症机械通气患者中,丙泊酚60毫克/毫升与丙泊酚10毫克/毫升的长期镇静效果比较。
Acta Anaesthesiol Scand. 2004 Mar;48(3):302-7. doi: 10.1111/j.1399-6576.2004.0339.x.
6
Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.环丙沙星在接受持续静脉-静脉血液透析滤过的重症监护病房患者中的药代动力学。
Intensive Care Med. 2001 Apr;27(4):665-72. doi: 10.1007/s001340100857.
7
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.丙泊酚用于重症患者长期镇静的群体药代动力学和药效学建模:丙泊酚6%与丙泊酚1%的比较
Clin Pharmacol Ther. 2002 Dec;72(6):670-84. doi: 10.1067/mcp.2002.129500.
8
Case report: requirement of supplemental morphine during sedation with propofol in a critically ill patient undergoing hemodiafiltration.病例报告:一名接受血液透析滤过的重症患者在丙泊酚镇静期间对补充吗啡的需求
MedGenMed. 2003 Nov 12;5(4):22.
9
A service evaluation comparing CVVH an CVVHD in minimising circuit failure.一项比较连续性静脉-静脉血液滤过(CVVH)和连续性静脉-静脉血液透析滤过(CVVHD)在减少体外循环失败方面的服务评估。
Nurs Crit Care. 2017 Jan;22(1):52-57. doi: 10.1111/nicc.12230. Epub 2016 Feb 12.
10
[Application of propofol sedation in patients undergoing continuous venous-venous haemodiafiltration].丙泊酚镇静在接受持续静脉-静脉血液透析滤过患者中的应用
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Jul;25(7):408-10. doi: 10.3760/cma.j.issn.2095-4352.2013.07.009.

引用本文的文献

1
Sedation for Patients with Sepsis: Towards a Personalised Approach.脓毒症患者的镇静:迈向个性化治疗方法
J Pers Med. 2023 Nov 24;13(12):1641. doi: 10.3390/jpm13121641.
2
Propofol: a review of its use in intensive care sedation of adults.丙泊酚:关于其在成人重症监护镇静中的应用综述
CNS Drugs. 2003;17(4):235-72. doi: 10.2165/00023210-200317040-00003.
3
Pharmacokinetics of drugs used in critically ill adults.危重症成年患者使用药物的药代动力学

本文引用的文献

1
APACHE II: a severity of disease classification system.急性生理与慢性健康状况评分系统II:一种疾病严重程度分类系统。
Crit Care Med. 1985 Oct;13(10):818-29.
2
Pathogenesis and management of lipoprotein disorders.
N Engl J Med. 1985 May 16;312(20):1300-10. doi: 10.1056/NEJM198505163122007.
3
Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection.高效液相色谱荧光检测法测定血液中丙泊酚的改进方法
J Chromatogr. 1987 Oct 9;421(1):171-6. doi: 10.1016/0378-4347(87)80394-8.
Clin Pharmacokinet. 1998 Jan;34(1):25-56. doi: 10.2165/00003088-199834010-00002.
4
Inorganic fluoride concentration after long-term sedation with isoflurane.
Intensive Care Med. 1996 Jul;22(7):677-82. doi: 10.1007/BF01709746.
5
Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.丙泊酚。其药理学概述及在重症监护镇静中临床疗效的综述。
Drugs. 1995 Oct;50(4):636-57. doi: 10.2165/00003495-199550040-00006.
4
Propofol infusion for sedation in intensive care.
Anaesthesia. 1987 Sep;42(9):929-37. doi: 10.1111/j.1365-2044.1987.tb05362.x.
5
Pharmacokinetics of propofol in female patients. Studies using single bolus injections.丙泊酚在女性患者中的药代动力学。采用单次推注注射的研究。
Br J Anaesth. 1987 Sep;59(9):1103-10. doi: 10.1093/bja/59.9.1103.
6
Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion.
Br J Anaesth. 1988 Nov;61(5):583-8. doi: 10.1093/bja/61.5.583.
7
Pharmacokinetics and protein binding of propofol in patients with cirrhosis.丙泊酚在肝硬化患者中的药代动力学及蛋白结合情况
Anesthesiology. 1988 Dec;69(6):887-91. doi: 10.1097/00000542-198812000-00014.
8
Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.全身麻醉期间丙泊酚输注的药代动力学和药效学
Anesthesiology. 1988 Sep;69(3):348-56. doi: 10.1097/00000542-198809000-00011.
9
Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.14C-丙泊酚水包油乳剂亚麻醉静脉剂量在男性志愿者体内的处置情况。
Xenobiotica. 1988 Apr;18(4):429-40. doi: 10.3109/00498258809041679.
10
Propofol infusion for sedation in the intensive care unit: preliminary report.重症监护病房中丙泊酚输注用于镇静:初步报告。
Br Med J (Clin Res Ed). 1987 Feb 14;294(6569):397-400. doi: 10.1136/bmj.294.6569.397.